Bone disease in patients with haemophilia A and B--where are we now?

Area of Science:

• Orthopedics
• Hematology
• Endocrinology

Background:

• Hemophilia A and B are linked to diminished bone mass in pediatric and adult patients.
• Factors contributing to bone loss include reduced physical activity, vitamin D deficiency, and potentially Hepatitis C virus (HCV) infection.
• Existing research on osteoporosis prevalence and pathogenesis in hemophilia is limited by small sample sizes and study heterogeneity.

Purpose of the Study:

• To review the current understanding of bone mass reduction in hemophilia.
• To identify contributing factors and knowledge gaps regarding osteoporosis in hemophilia patients.
• To provide recommendations for fracture risk assessment and management.

Main Methods:

• Literature review of studies investigating bone mineral density (BMD) and fracture risk in hemophilia.
• Analysis of factors associated with decreased bone mass, including physical activity, vitamin D levels, and HCV infection.
• Evaluation of current recommendations for osteoporosis screening and treatment.

Main Results:

• Consistent association between hemophilia A and B and decreased bone mass across age groups.
• Identified contributing factors: decreased physical activity, vitamin D deficiency, and HCV infection.
• Heterogeneity in study findings regarding specific skeletal sites of low BMD and sparse data on fracture risk.

Conclusions:

• Recommendations include regular BMD assessment starting at age 25, utilizing the Fracture Risk Assessment Tool (FRAX), and optimizing calcium and vitamin D intake.
• Management strategies may involve prophylactic factor replacement therapy, resistance exercise, and bisphosphonates for high-risk individuals.
• Further research is warranted to establish definitive conclusions on osteoporosis prevalence and pathogenesis in hemophilia.